235 related articles for article (PubMed ID: 4970947)
1. Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation.
Fisher B; Ravdin RG; Ausman RK; Slack NH; Moore GE; Noer RJ
Ann Surg; 1968 Sep; 168(3):337-56. PubMed ID: 4970947
[No Abstract] [Full Text] [Related]
2. Extended surgical adjuvant thiotepa for mammary carcinoma.
Donegan WL
Arch Surg; 1974 Aug; 109(2):187-92. PubMed ID: 4211024
[No Abstract] [Full Text] [Related]
3. Extended surgical adjuvant chemotherapy for breast carcinoma.
Long RT; Donegan WL; Evans AM
Am J Surg; 1969 May; 117(5):701-4. PubMed ID: 4978185
[No Abstract] [Full Text] [Related]
4. Controversies in the management of potentially curable breast cancer.
Wise L
Surg Annu; 1974; 6():247-81. PubMed ID: 4215164
[No Abstract] [Full Text] [Related]
5. Systemic chemotherapy as an adjuvant to surgery in the treatment of breast cancer.
Fisher B
Cancer; 1969 Dec; 24(6):1286-9. PubMed ID: 4982124
[No Abstract] [Full Text] [Related]
6. Therapeutic implications from a mathematical model characterizing the course of breast cancer.
Slack NH; Blumenson LE; Bross ID
Cancer; 1969 Nov; 24(5):960-71. PubMed ID: 4982121
[No Abstract] [Full Text] [Related]
7. Chemotherapy in primary therapy of cancer of the breast.
Ansfield FJ
Cancer; 1967 Jul; 20(7):1054-5. PubMed ID: 4961154
[No Abstract] [Full Text] [Related]
8. [Late results of observing patients with extensive breast cancer who have undergone chemotherapy by infusion].
Vikmanis UE; Sviatukhina OV; Lun'kova EF
Vopr Onkol; 1974; 20(1):6-11. PubMed ID: 4216150
[No Abstract] [Full Text] [Related]
9. The relationship of menstrual status and other risk factors to recurrence of carcinoma of the breast.
Hyman B; Myers MH; Schottenfeld D
Am J Epidemiol; 1972 Sep; 96(3):173-82. PubMed ID: 5070027
[No Abstract] [Full Text] [Related]
10. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
Brincker H; Rose C; Rank F; Mouridsen HT; Jakobsen A; Dombernowsky P; Panduro J; Andersen KW
J Clin Oncol; 1987 Nov; 5(11):1771-8. PubMed ID: 3316514
[TBL] [Abstract][Full Text] [Related]
11. United States trials of adjuvant therapy.
Fisher B
World J Surg; 1977 May; 1(3):331-5. PubMed ID: 407729
[No Abstract] [Full Text] [Related]
12. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
Levitt SH; Potish RA
Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
[TBL] [Abstract][Full Text] [Related]
13. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.
Fisher B; Slack N; Katrych D; Wolmark N
Surg Gynecol Obstet; 1975 Apr; 140(4):528-34. PubMed ID: 805475
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy for breast cancer.
Holland JF
Surg Clin North Am; 1981 Dec; 61(6):1361-70. PubMed ID: 6797078
[No Abstract] [Full Text] [Related]
15. [Adjuvant chemotherapy in breast cancer: status in 1984].
Jungi WF
Wien Klin Wochenschr; 1984 Jun; 96(13):486-92. PubMed ID: 6382805
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
Conrad B; Kieser R
Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
[TBL] [Abstract][Full Text] [Related]
17. Complications and toxic manifestations of surgical adjuvant chemotherapy for breast cancer.
Cohn I
Surg Gynecol Obstet; 1968 Dec; 127(6):1201-9. PubMed ID: 4973320
[No Abstract] [Full Text] [Related]
18. Adjuvant long-term chemotherapy in complex treatment of operable breast cancer.
Kholdin SA; Deemarsky LY; Bavly JL
Cancer; 1974 Apr; 33(4):903-6. PubMed ID: 4206571
[No Abstract] [Full Text] [Related]
19. [Comparative evaluation of thiphosphamide, cyclophosphane, methotrexate and 5-fluorouracil in the treatment of breast cancer].
Sokolova VD; Perevodchikova NI
Vestn Akad Med Nauk SSSR; 1971; 26(3):59-65. PubMed ID: 4996463
[No Abstract] [Full Text] [Related]
20. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
